HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Clinical trials for HUMAN IMMUNODEFICIENCY VIRUS (HIV) explained in plain language.
Never miss a new study
Get alerted when new HUMAN IMMUNODEFICIENCY VIRUS (HIV) trials appear
Sign up with your email to follow new studies for HUMAN IMMUNODEFICIENCY VIRUS (HIV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New HIV vaccine candidate moves to human safety testing
⭐️ VACCINE ⭐️ CompletedThis study tested an experimental HIV vaccine in 65 healthy, HIV-negative adults to see if it is safe and triggers an immune response. Participants received three shots over two months, each with a different dose of an immune-boosting ingredient called ALFQ. The goal was to find …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: PHASE1 • Sponsor: U.S. Army Medical Research and Development Command • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 04:41 UTC
-
Vitamin D3 shows promise for HIV immune health
Disease control CompletedThis study looked at whether taking vitamin D3 for 3 months can reduce inflammation and improve immune cell counts in people with HIV who are already on antiretroviral therapy. Twenty adults with early-stage HIV took part. Researchers measured changes in a marker of inflammation …
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Universitas Sebelas Maret • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Rural oklahoma program aims to stop HIV before it starts
Prevention CompletedThis study tested a program to help young men in rural Oklahoma—especially American Indian and gay or bisexual men—prevent HIV. The program offered at-home HIV tests, promoted condom use, and encouraged PrEP, a daily pill that prevents HIV. Researchers worked with community advis…
Matched conditions: HUMAN IMMUNODEFICIENCY VIRUS (HIV)
Phase: NA • Sponsor: Northern Arizona University • Aim: Prevention
Last updated May 19, 2026 11:46 UTC